Biotech start-up AnHorn Medicines Co (安宏生醫) yesterday completed a series A funding of US$10 million, as its proprietary protein degrader and artificial intelligence (AI)-enabled screening platform attracted investors, the company said.
AnHorn said it would use the fund for research and development and to support future operations.
Investors in the series A financing include Taiwania Capital Management Corp (台杉投資管理), the Industrial Technology Research Institute (工研院), Hong Tai Electric Industrial Co (宏泰電工), Sunplus Technology Co (凌陽科技) and Black Marble Capital Management Co (萬豐資本), the company said.
AnHorn said it is developing a new protein degrader, dubbed BIGPRO, that can precisely eliminate disease protein and help the human body become healthy.
The drug can be used to address a broad range of life-threatening diseases, with a focus on the treatment of cancer and neuro-degeneration, the company said.
Developing protein degraders is a new trend in the healthcare business as the small-molecule drug costs less in production than large-molecule drugs, it said, adding that its outlook is promising.
With its expertise in chemistry and pharmacology, the company’s AI-enabled screening platform can speed up the process of finding durable proteins and boost research efficiency, AnHorn chairman Lin Chu-Chiang (林助強) said.
Following its establishment in 2020 with paid-in capital of NT$1 billion (US$32.59 million), the company has developed two experimental drug candidates, Lin said.
The company plans to apply an investigational new drug for one candidate from the US Food and Drug Administration next year, enabling it to enter phase 1 clinical trials, he said.
Semiconductor shares in China surged yesterday after Reuters reported the US had ordered chipmaking giant Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) to halt shipments of advanced chips to Chinese customers, which investors believe could accelerate Beijing’s self-reliance efforts. TSMC yesterday started to suspend shipments of certain sophisticated chips to some Chinese clients after receiving a letter from the US Department of Commerce imposing export restrictions on those products, Reuters reported on Sunday, citing an unnamed source. The US imposed export restrictions on TSMC’s 7-nanometer or more advanced designs, Reuters reported. Investors figured that would encourage authorities to support China’s industry and bought shares
FLEXIBLE: Taiwan can develop its own ground station equipment, and has highly competitive manufacturers and suppliers with diversified production, the MOEA said The Ministry of Economic Affairs (MOEA) yesterday disputed reports that suppliers to US-based Space Exploration Technologies Corp (SpaceX) had been asked to move production out of Taiwan. Reuters had reported on Tuesday last week that Elon Musk-owned SpaceX had asked their manufacturers to produce outside of Taiwan given geopolitical risks and that at least one Taiwanese supplier had been pushed to relocate production to Vietnam. SpaceX’s requests place a renewed focus on the contentious relationship Musk has had with Taiwan, especially after he said last year that Taiwan is an “integral part” of China, sparking sharp criticism from Taiwanese authorities. The ministry said
US President Joe Biden’s administration is racing to complete CHIPS and Science Act agreements with companies such as Intel Corp and Samsung Electronics Co, aiming to shore up one of its signature initiatives before US president-elect Donald Trump enters the White House. The US Department of Commerce has allocated more than 90 percent of the US$39 billion in grants under the act, a landmark law enacted in 2022 designed to rebuild the domestic chip industry. However, the agency has only announced one binding agreement so far. The next two months would prove critical for more than 20 companies still in the process
CHANGING JAPAN: Nvidia-powered AI services over cellular networks ‘will result in an artificial intelligence grid that runs across Japan,’ Nvidia’s Jensen Huang said Softbank Group Corp would be the first to build a supercomputer with chips using Nvidia Corp’s new Blackwell design, a demonstration of the Japanese company’s ambitions to catch up on artificial intelligence (AI). The group’s telecom unit, Softbank Corp, plans to build Japan’s most powerful AI supercomputer to support local services, it said. That computer would be based on Nvidia’s DGX B200 product, which combines computer processors with so-called AI accelerator chips. A follow-up effort will feature Grace Blackwell, a more advanced version, the company said. The announcement indicates that Softbank Group, which until early 2019 owned 4.9 percent of Nvidia, has secured a
RSS